NephroGenex Inc Stock

Stocks

15-01-08

16-05-02	NephroGenex, Inc. : Commences Voluntary Chapter 11 Proceeding; Seeks To Initiate Sale Process Under Section 363	BU
16-02-24	NephroGenex : Provides Corporate Update	BU
16-02-16	NephroGenex : to Host Conference Call and Webcast on Fourth Quarter and Full Year 2015 Financial Results on Thursday, February 25, 2016	BU
16-01-27	NephroGenex : to Present at the 18th Annual BIO CEO & Investor Conference	BU
16-01-21	NephroGenex : Announces Independent DSMB Recommendation to Continue Phase 3 Study of Oral Pyridorin in Diabetic Nephropathy Without Modification	BU

14-12-31	Wall Street finit dans le rouge une année faste
14-12-31	DJ Industrial : Wall Street finit dans le rouge une année faste
14-12-31	NephroGenex : Wall Street ouvre en légère hausse sa dernière séance de 2014
14-12-31	USA-Les valeurs à suivre à Wall Street

Manager	Title	Age	Since
Kevin Brady DFI	Director of Finance/CFO	51	2021-07-31
Jesse Geiger PSD	President	51	2021-07-31
Stephen Ewald SEC	Corporate Secretary	56	2012-05-31

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
NEPHROGENEX INC	-.--%	-.--%	-	-	0
WUXI APPTEC CO., LTD.	-0.38%	-0.99%	+42.69%	+100.85%	67.82B
ARGENX SE	-0.58%	-2.44%	+33.34%	+78.38%	63.22B
INSMED INCORPORATED	-0.31%	+3.67%	-12.96%	+374.95%	27.58B
BIONTECH SE	+0.86%	+2.12%	-7.74%	-13.34%	26.06B
WUXI BIOLOGICS (CAYMAN) INC.	+1.69%	-0.36%	+26.48%	+15.46%	25.38B
GENMAB A/S	+1.49%	+1.12%	+24.84%	-17.61%	19.89B
PHARMAESSENTIA CORPORATION	+1.15%	-5.02%	+219.82%	+379.02%	17.4B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-0.49%	-0.37%	-7.31%	+524.84%	14.95B
EXELIXIS, INC.	-0.20%	+8.00%	+55.78%	+167.98%	14.62B
Average	+0.33%	+1.67%	+41.66%	+178.95%	30.77B
Weighted average by Cap.	+0.13%	+0.90%	+36.62%	+139.85%